Literature DB >> 30867105

Endometrial Cancer: An Overview of Pathophysiology, Management, and Care.

Kelly Passarello1, Shiney Kurian2, Valerie Villanueva2.   

Abstract

OBJECTIVE: To provide an overview of the etiology, diagnosis, treatment, and survivorship concerns surrounding endometrial cancer. DATA SOURCES: A review of articles dated 2006-2018 from PubMed and NCCN guidelines.
CONCLUSION: Endometrial cancer is the most common gynecologic malignancy. Staging and treatment are primarily surgical, with adjuvant radiation and chemotherapy administered as indicated by grade and stage. IMPLICATIONS FOR NURSING PRACTICE: Cancer prevention, response to treatment, and quality of life can be affected by lifestyle factors, including nutrition, exercise, and tobacco use. Nurses in diverse roles and practice settings can educate patients about lifestyle choices that can affect individuals across the cancer trajectory.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  diagnosis; endometrial cancer; survivorship; treatment

Year:  2019        PMID: 30867105     DOI: 10.1016/j.soncn.2019.02.002

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  30 in total

Review 1.  Pre-treatment sarcopenic assessments as a prognostic factor for gynaecology cancer outcomes: systematic review and meta-analysis.

Authors:  E H Sutton; M Plyta; K Fragkos; S Di Caro
Journal:  Eur J Clin Nutr       Date:  2022-02-22       Impact factor: 4.016

2.  Role of MRI in diagnosing the primary site of origin in indeterminate cases of uterocervical carcinomas: a systematic review and meta-analysis.

Authors:  Pooja Jain; Ankita Aggarwal; Rohini Gupta Ghasi; Amita Malik; Ritu Nair Misra; Kanwaljeet Garg
Journal:  Br J Radiol       Date:  2021-10-28       Impact factor: 3.039

3.  Single cell sequencing analysis and transcriptome analysis constructed the liquid-liquid phase separation(LLPS)-related prognostic model for endometrial cancer.

Authors:  Jiayang Wang; Fei Meng; Fei Mao
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

4.  Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer.

Authors:  Ning Li; Peng Jiang; Yuzhen Huang; Yuan Tu; Wei Kong; Shan Jiang; Jingni Zhang; Yijun Wu; Xiaorong Zhang; Qingning Xie; Rui Yuan
Journal:  Clin Med Insights Oncol       Date:  2022-06-15

Review 5.  Endometrial cancer from early to advanced-stage disease: an update for radiologists.

Authors:  Cibele Luna; Patricia Balcacer; Patricia Castillo; Marilyn Huang; Francesco Alessandrino
Journal:  Abdom Radiol (NY)       Date:  2021-07-23

6.  Clinicopathological Characteristics and Prognosis in Endometrial Cancer With Bone Metastasis: A SEER-Based Study of 584 Women.

Authors:  Hejia Hu; Zhan Wang; Miaofeng Zhang; Feng Niu; Qunfei Yu; Ying Ren; Zhaoming Ye
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

7.  Improvements in strength and agility measures of functional fitness following a telehealth-delivered home-based exercise intervention in endometrial cancer survivors.

Authors:  Jessica S Gorzelitz; Stefanie Stoller; Erin Costanzo; Ronald Gangnon; Kelli Koltyn; Amy Trentham Dietz; Ryan J Spencer; Joanne Rash; Lisa Cadmus-Bertram
Journal:  Support Care Cancer       Date:  2021-07-25       Impact factor: 3.359

Review 8.  Obesity: novel and unusual predisposing factors.

Authors:  Petra Hanson; Martin O Weickert; Thomas M Barber
Journal:  Ther Adv Endocrinol Metab       Date:  2020-05-19       Impact factor: 3.565

9.  Curcumin Inhibits ERK/c-Jun Expressions and Phosphorylation against Endometrial Carcinoma.

Authors:  Zhenxue Zhang; Pengfei Yi; Changchun Tu; Jiejie Zhan; Liping Jiang; Fanglin Zhang
Journal:  Biomed Res Int       Date:  2019-10-31       Impact factor: 3.411

Review 10.  The Role of Hyperglycemia in Endometrial Cancer Pathogenesis.

Authors:  Frances L Byrne; Amy R Martin; Melidya Kosasih; Beth T Caruana; Rhonda Farrell
Journal:  Cancers (Basel)       Date:  2020-05-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.